|
Time |
WEBINAR |
Speaker |
|---|---|---|
|
1130 - 1200 |
Registration |
|
|
1200 - 1300 |
E-cigarette Addiction Prevention and Management |
Mohamad Haniki Nik Mohamed, Malaysia |
|
1310 - 1340 |
EVALI: Epidemiology and Presentations |
Mohd Afiq Mohd Nor, Malaysia |
|
1340 - 1410 |
Break |
|
|
1410 - 1455 |
EVALI Investigations |
Tie Siew Teck, Malaysia |
|
1505 - 1555 |
Imaging findings of EVALI |
Zuhanis Abdul Hamid. Malaysia |
|
1605 - 1655 |
Management of EVALI |
Tie Siew Teck, Malaysia |
|
1655 - 1700 |
Closing |
|
|
Time |
SPONSORED SYMPOSIUM 1 (SS1) |
|---|---|
|
1845 - 1935 |
Company: Orient Europharma |
|
Time |
Programme |
|---|---|
|
0800 - 0810 |
WELCOME ADDRESS
|
|
0810 - 0850 |
PLENARY 1 (P1) Non-Invasive Ventilation - A Glimpse into the Future |
|
|
SYMPOSIUM 1 (S1) |
|
0850 - 1005 |
S1A – MTS-APSR Joint Symposium 1: Lung Cancer
Targeted Therapy for NSCLC – Old and New Approach to Solitary Pulmonary Nodule Lung Cancer Screening and the Impact on Thoracic Surgery |
|
0850 - 1005 |
S1B – Airways Diseases
Bronchial Asthma & Short Acting B2 Agonists: The Unbreakable Affair Pulmonary Rehabilitation & COPD End of Life Planning for Patients with Advanced COPD |
|
0850 - 1005 |
S1C – Sleep Disordered Breathing (SDB) in Children
Snoring in Children, When to Worry? Clinical Presentation of OSA in Infant Principle in Management of Children with SDB |
|
1005 - 1035 |
COFFEE BREAK |
|
|
SYMPOSIUM 2 (S2) |
|
1035 - 1150 |
S2A – MTS-APSR Joint Symposium 2: Lung Cancer
Neoadjuvant Chemotherapy & Surgery VS Concurrent Chemoradiotherapy & Immunotherapy in Resectable N2 stage IIIA Lung Cancer: Debate Management of Immunotherapy Related Pulmonary Toxicity Ground Glass Opacity - Diagnostic Approach and Management |
|
1035 - 1150 |
S2B – Sleep Disordered Breathing
Long Term Treatment in Obesity Hypoventilation Syndrome:NIV vs CPAP? Treatment of Mild OSA: Should We Bother Treating It? Pre-operative Screening for OSA: Is This Evidence-based? |
|
1035 - 1150 |
S2C – Paediatric Aero-digestive Diseases
Chairpersons: Eg Kah Peng/Su Siew Choo
Assessment of Swallowing Function in Children GERD in Children Aspiration Related Lung Disease |
|
1150 - 1240 |
SPONSORED SYMPOSIUM 2 (SS2) Company: AstraZeneca Chairpersons: Liam Chong Kin Reframing Asthma Care: Say NO to SABA Monotherapy Clinical Treatment Options in NSCLC Patient Harbouring EGFRm – Where does the Path Go |
|
1240 - 1430 |
LUNCH BREAK & FRIDAY PRAYERS |
|
|
SYMPOSIUM 3 (S3) |
|
1430 - 1600 |
S3A – Interstitial Lung Disease 1
Chairpersons: Syazatul Syakirin / Noorul Afidza
Antifibrotics for Fibrotic Lung Disease: Beyond Idiopathic Pulmonary Fibrosis HRCT Interpretation in Idiopathic Pulmonary Fibrosis Interstitial Lung Disease in CTD: Evolving Concepts of Pathogenesis and Management |
|
1430 - 1600 |
S3B – Interventional Pulmonology
Chairpersons: Narasimman Sathiamurthy / Fauzi Md Anshar
Bronchoscopic Sampling of Peripheral Lung Nodule Role of Bronchoscopy in Malignant Central Airway Obstruction Role of Biopsy in Suspicious Lung Nodules - Is It Always Necessary? |
|
1430 - 1600 |
S3C – Children with Bronchiolitis Obliterans
Chairpersons: Rus Anida Awang/Alison Ting Yih Hua
Who are at Risk for Bronchiolitis Obliterans? Assessment of Children with Bronchiolitis Obliterans Management of Bronchiolitis Obliterans, What's New? |
|
1600 - 1650 |
SPONSORED SYMPOSIUM 3A Company: Sanofi Pasteur Chairperson: Lalitha Pereirasamy
Influenza: A Threat to Patients with Respiratory Conditions |
|
SPONSORED SYMPOSIUM 3B Company: Viatris Chairperson: Lem Li Khen
Management of Allergic Rhinitis in Comorbid Asthma Patients: Towards the Right Combination |
|
|
1650 - 1845 |
COFFEE BREAK |
|
1845 - 1935 |
SPONSORED SYMPOSIUM 4A Company: Merck Sharp & Dohme Chairperson: Yivonn Khoo
Challenges in the Management of Hospital Acquired Pneumonia in the Era of Multi-drug Resistance |
|
Time |
Programme |
|---|---|
|
0800 - 0840 |
PLENARY 2 (P2) Chairperson: Asiah Kassim Recent COVID-19 Pandemic, Sharing Experience in Italy |
|
0850 - 1010 |
SYMPOSIUM 4 |
|
0850 - 1010
|
S4A – Pulmonary Vascular Disease Chairpersons: Roslina Abdul Manap / Nurhayati Mohd Marzuki Pulmonary Arterial Hypertension (PAH): The changing landscape of treatment Common Concerns in PAH: Travel, Exercise, Surgery, Pregnancy: How to Manage? Management of Pulmonary Arteriovenous Malformation |
| 0850 - 1010 |
S4B – Pleural Diseases Practice Changing Clinical Trials in Malignant Pleural Effusions |
| 0850 - 1010 |
S4C – Asthma and Wheezing
Evaluation of Pre-school Wheeze: Asthma or Not Asthma? |
|
1010 - 1040 |
COFFEE BREAK |
|
1040 - 1210 |
SYMPOSIUM 5 |
|
1040 - 1210
|
S5A – Interstitial Lung Disease 2: Case Based Discussion Case 1: Interstitial Lung Disease - Non IPF Case 2: CTD Related ILD Case 3: Idiopathic Pulmonary Fibrosis |
| 1040 - 1210 |
S5B – Tuberculosis MDR-TB: An Update Challenges in Diagnosis & Management of Spine Tuberculosis Latent TB: Prevent or Treat |
| 1040 - 1210 |
S5C – Chronic Cough in Children Chronic Cough in Children, What to Worry? Protracted Bacterial Bronchitis, Is It Real? Non-CF Bronchiectasis |
|
1210 - 1300 |
SPONSORED SYMPOSIUM 5 (SS5) Company: Boehringer Ingelheim |
|
1300 - 1400 |
LUNCH |
|
1400 - 1500 |
SYMPOSIUM 6 (S6) |
|
S6A – Oral Presentation Chairperson: Lalitha Pereirasamy / Eg Kah Peng |
|
| S6B – Poster Presentation | |
|
1500 - 1550 |
SPONSORED SYMPOSIUM 6 (SS6) |
|
1550 - 1640 |
SPONSORED SYMPOSIUM 7A (SS7A) |
|
SPONSORED SYMPOSIUM 7B (SS7B) |
|
|
1640 - 1710 |
COFFEE BREAK |
|
1640 - 1730 |
SPONSORED SYMPOSIUM 8 (SS8) |
|
1730 - 1800 |
Announcement of Awards (Poster & Oral) Scientific Committee: Lalitha Pereirasamy and Eg Kah Peng
|
|
Time |
Programme |
|---|---|
|
0830 - 0915 |
KEYNOTE ADDRESS Battling COVID-19 in Malaysia |
|
0915 - 1015 |
SYMPOSIUM 8 (S8) |
|
0915 - 1015 |
S8A – COVID-19 Highlights Biology of SARS-COV2 Respiratory Support in COVID-19: Pre/Post Ventilation & ECMO |
|
1015 - 1040 |
COFFEE BREAK |
|
1040 - 1130 |
S8B – Thoracic Radiology Radiology Rapid Fire – Radiology Quiz
|
|
1130 - 1245 |
SYMPOSIUM 9 (S9) |
|
1130 - 1245 |
S9A – COVID-19 Highlights Up-to-date Clinical Management of COVID-19 Strategies for COVID-19 Vaccine Long Term Care in Post COVID-19 Patients |
| 1130 - 1245 |
S9B – Tuberculosis in Children When to Consider TB Treatment Failure Contact Tracing and Latent TB Infection Multi-drug Resistant Tuberculosis |
|
1245 - 1300 |
CLOSING CEREMONY Rozanah Abd Rahman |